top of page
Our Solutions & Products
Microbiome Intelligence Panel for IBD
A comprehensive microbiome intelligence product that combines multiple recurrent DNA tests with the analysis of blood data, imaging, and advanced user profiling, culminating in highly personalized recommendations and treatment suggestions for each IBD patient.
#best for IBD assisted therapy
Microbiome Screening Panel for Oncology
A microbiome intelligence product tailored for oncology, providing doctors with a detailed analysis of potential microbiome elements that may affect disease progression. It also offers modulation suggestions to enhance therapeutic efficacy for each patient across various types of cancer.
#best for Oncology
All inclusive treatment personalization for IBD
A complete testing and treatment management package for IBD patients who directly seek NostraBiome's services. This is a super premium, white-glove service offered through telemedicine and direct interactions with our internal medical and science team
#most personalized for IBD
Fully Certified
1. The prelevation at-home kit is CE-certified, ensuring compliance with health, safety, and environmental protection standards within the European Economic Area.
2. Our AI platform exclusively utilizes data derived from medically certified and trusted clinical sources, ensuring the highest level of reliability and accuracy.
3. The sequencing pipeline operates entirely within clinically certified facilities, adhering to stringent medical standards and protocols.
4. The bioinformatics pipeline is clinically certified, guaranteeing that all data processing meets established clinical compliance and safety requirements.
5. All recommendations and the final intelligence report are rigorously reviewed and endorsed by a qualified doctor, ensuring professional oversight and accountability.
Non-invasive
Only stool sampling is required to perform a comprehensive microbial DNA analysis, leveraging existing medical information, historical blood data, and patient responses to our proprietary active questionaire technology.
Our methods efficiently gather all necessary data to provide complex insights, diagnosis, and modulation recommendations without the need for invasive procedures.
Accurate
NostraBiome AI demonstrates an accuracy exceeding 85% in predicting modulation outcomes within microbial populations and interactions o microbiome with immune pathways.
This high level of precision is attributed to our proprietary technology platform, which is grounded on an extensive foundation of more than 40,000 medical papers and bolstered by innovations encompassed in over 100 patents held by our team members.
Request a demo example
If you are a doctor looking to get more details about our solutions, please reach out to us
bottom of page